Hydroxychloroquine Market By Type (USP Standards Grade, Pharmaceutical Standards Grade, EP Standards Grade and Others), By Application (Rheumatoid Arthritis, Skin Lesions, Systemic Lupus Erythematosus, Chronic Discoid Lupus Erythematosus and Others)
Hydroxychloroquine Market By Type (USP Standards Grade, Pharmaceutical Standards Grade, EP Standards Grade and Others), By Application (Rheumatoid Arthritis, Skin Lesions, Systemic Lupus Erythematosus, Chronic Discoid Lupus Erythematosus and Others)
Insights into the Hydroxychloroquine Market include supply chain optimization, Hydroxychloroquine challenges, and growth forecasts segmented by region and service type.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Global Hydroxychloroquine Market By Type (USP Standards Grade, Pharmaceutical Standards Grade, EP Standards Grade and Others), By Application (Rheumatoid Arthritis, Skin Lesions, Systemic Lupus Erythematosus, Chronic Discoid Lupus Erythematosus and Others)
Hydroxychloroquine Market is valued at 548.21 USD Million in 2018 and expected to reach USD 1367.66 Billion by 2026 with the CAGR of 13.96% over the forecast period.
Scope of the report
This report analyses the global market for Hydroxychloroquine. The report will enable the user to understand and gain insights into the current and forecast market situation. The market is comprehensively analyzed by geography to provide complete information on the global scenario. The qualitative and quantitative data provided in this study can help user understand which market segments are expected to grow at higher rates, factors affecting the market and key opportunity areas. The report also includes competitive landscape of key players in the industry along with emerging trends in the market.
Industry Overview
Hydroxychloroquine is a medication used to treat malaria and certain auto-immune disorders. It is used in the treatment of rheumatoid arthritis (RA) and lupus. Demand for Hydroxychloroquine has skyrocketed due to the surprising efficacy in treatment of coronavirus. However, the drug is not approved by the U.S. FDA to treat coronavirus. Hydroxychloroquine sulfate was sold across the world, led by the United States which accounted for more than a quarter of the amount, followed by India and China, consuming 20% and 12%, respectively. Majority of the prescriptions in the US were for chronic indications such as Rheumatoid arthritis and systemic lupus erythematosus. Demand for Hydroxychloroquine in US and global is expected to increase in future owing to prevalence of rheumatoid arthritis, autoimmune disorders and anticipated application in coronavirus treatment.
Key Players
Sandoz,TEVA,Novartis, Mylan,HIKMA,IPCA,SHANGHAI PHARMA,Shenhua Pharm,Sanofi,H-QYN,TAJ Pharma,MAAN Medex,Cinkate,Concordia Healthcare,Shanghai Zhongxisanwei, Wuhan Wuyao Pharmaceutical and others
Above mentioned companies are scrutinized to assess competitive landscape of global Hydroxychloroquine market. Report provides company profiles of each player. Each profile include company business overview, company governance, company product portfolio, company financials, business strategies, manufacturing locations and production facilities, company sale, production capacity, recent developments and strategic collaborations and partnerships, product launch, company segments, application diversification and company strength and weakness analysis.
Review period
Historic Period: 2016 to 2020
Forecast Period: 2020 to 2026
This Hydroxychloroquine market report provides insights on new trade regulations, import export analysis, industry value chain analysis, market size, consumption, production analysis, capacity analysis, regional and segment market share, product launches, product pipeline analysis, impact of Covid-19 on supply chain, key regions, untapped markets, patent analysis, product approvals, continuous innovations and developments in the market.
Regions
• North America: U.S., Canada and Rest of North America
• Europe: UK, France, Germany, Italy, Spain and Rest of Europe
• Asia Pacific: China, Japan, India, Australia and Southeast Asia and Rest of Asia Pacific
• Latin America: Brazil, Argentina and Rest of Latin America
• Middle East and Africa: Gulf Countries, Israel, Africa and Rest of Middle East and Africa
Market Segmentation
• Type
o USP Standards Grade
o Pharmaceutical Standards Grade
o EP Standards Grade
o Others
• Application
o Rheumatoid Arthritis
o Skin Lesions
o Systemic Lupus Erythematosus
o Chronic Discoid Lupus Erythematosus
o Others
Regional Insights
Asia pacific dominates the global Hydroxychloroquine Market. The region is largest producer and exporter of Hydroxychloroquine. India is the largest producer of Hydroxychloroquine in the world. India undoubtedly plays a central role for the global supply of Hydroxychloroquine, due to its leading API manufacturers and sophisticated generic drug manufacturing industry. It is estimated that the country produces roughly more than 60 metric tons of Hydroxychloroquine for domestic market dominated by Ipca Laboratories Ltd. with 80% market share and similar amount for export led by Zydus Cadila. Ipca is also the world's leading producer of chloroquine (di)phosphate, once having an 80% share of the global market. China's Hydroxychloroquine industry has been led by Shanghai Pharma with 80% share in 2018. The country produced roughly 35 metric tons of Hydroxychloroquine for domestic market, and 20 tons for exporting.
Factors Affecting the Market
Global hydroxychloroquine market is driven by the prevalence of malaria and rheumatoid arthritis. According to World Health Organization there were an estimated 228 million cases of malaria worldwide in 2018. The estimated number of malaria deaths stood at 40,5000 in 2018. The disease mostly affects Children aged under 5 years in 2018, they accounted for 67% (272 000) of all malaria deaths worldwide. In addition, Rheumatoid arthritis affects more than 1.3 million people in the United States. It is 2.5 times more common in women than in men. An estimated 78 million (26%) US adults aged 18 years or older are projected to have doctor-diagnosed arthritis by 2040. Demand for Hydroxychloroquine has skyrocketed due to the surprising efficacy in treatment of coronavirus. The current worldwide Hydroxychloroquine demand is 300 metric ton mostly for chronic diseases. The COVID-19 demand, however, is an immediate surge. For example, if 2% of the US population needs treatment, 40 metric tons of Hydroxychloroquine would be need urgently. If, however, 20% of the US population needs to be treated, 400 metric tons of Hydroxychloroquine would be needed in weeks. Globally, 2% treatment rate means a requirement of 1000 metric tons of the drug in weeks, or 3 times the current world annual production capacity. This aspect will create lucrative growth avenues for the market over the ensuing years.
Important Questions Answered by Global Hydroxychloroquine Market Report
• Which is the largest and fastest-growing region
• What are the factors affecting growth of market
• What are Key trends and opportunity areas
• What are the major strategies adopted by leading market companies
1. Chapter Introduction
1.1. Report Description
1.2. Market Segmentation
1.3. Research Methodology
1.4. List of Abbreviations
2. Chapter Executive Summary
3. Market Overview
3.1. Market Definition
3.2. Market Scope
3.3. Market Drivers
3.4. Market Restraints
3.5. Market Opportunities and Trends
3.6. Porter’s five force analysis
3.7. SWOT Analysis
3.8. PEST Analysis
3.9. Patent Analysis
4. Chapter Hydroxychloroquine Market, By Type
4.1. Global Hydroxychloroquine Market By Type, Market Size and Forecast, 2016 -2026 (USD Million)
4.2. Global Hydroxychloroquine Market By Type Share, 2016 -2026 (%)
5. Chapter Hydroxychloroquine Market, By Application
5.1. Global Hydroxychloroquine Market By Application, Market Size and Forecast, 2016 -2026 (USD Million)
5.2. Global Hydroxychloroquine Market By Application Share, 2016 -2026 (%)
6. Chapter Hydroxychloroquine Market, By Region
6.1. NORTH AMERICA
6.1.1. Key Findings
6.1.2. North America Hydroxychloroquine Market, Size and Forecast, 2016 -2026 (USD Million)
6.1.3. Key market trends, growth factors and opportunities
6.1.4. North America Hydroxychloroquine Market by Country Market, Size and Forecast, 2016 -2026 (USD Million)
6.1.5. North America Hydroxychloroquine Market by Segments Market, Size and Forecast, 2016 -2026 (USD Million)
6.2. EUROPE
6.2.1. Key Findings
6.2.2. Europe Hydroxychloroquine Market, Size and Forecast, 2016 -2026 (USD Million)
6.2.3. Key market trends, growth factors and opportunities
6.2.4. Europe Hydroxychloroquine Market by Country Market, Size and Forecast, 2016 -2026 (USD Million)
6.2.5. Europe Hydroxychloroquine Market by Segments Market, Size and Forecast, 2016 -2026 (USD Million)
6.3. ASIA PACIFIC
6.3.1. Key Findings
6.3.2. Asia Pacific Hydroxychloroquine Market, Size and Forecast, 2016 -2026 (USD Million)
6.3.3. Key market trends, growth factors and opportunities
6.3.4. Asia Pacific Hydroxychloroquine Market by Country Market, Size and Forecast, 2016 -2026 (USD Million)
6.3.5. Asia Pacific Hydroxychloroquine Market by Segments Market, Size and Forecast, 2016 -2026 (USD Million)
6.4. LATIN AMERICA
6.4.1. Key Findings
6.4.2. Latin America Hydroxychloroquine Market, Size and Forecast, 2016 -2026 (USD Million)
6.4.3. Key market trends, growth factors and opportunities
6.4.4. Latin America Hydroxychloroquine Market by Country Market, Size and Forecast, 2016 -2026 (USD Million)
6.4.5. Latin America Hydroxychloroquine Market by Segments Market, Size and Forecast, 2016 -2026 (USD Million)
6.5. MIDDLE EAST AND AFRICA
6.5.1. Key Findings
6.5.2. Middle East and Africa Hydroxychloroquine Market, Size and Forecast, 2016 -2026 (USD Million)
6.5.3. Key market trends, growth factors and opportunities
6.5.4. Middle East and Africa Hydroxychloroquine Market by Country Market, Size and Forecast, 2016 -2026 (USD Million)
6.5.5. Middle East and Africa Hydroxychloroquine Market by Segments Market, Size and Forecast, 2016 -2026 (USD Million)
7. Chapter Competitive Landscape Analysis
7.1. Global Hydroxychloroquine Market Company Revenue, (USD Million), 2016-2019
7.2. Global Hydroxychloroquine Market Company Share, (%), 2016-2019
8. Chapter Company Profiles
8.1. Sandoz
8.2. TEVA
8.3. Novartis
8.4. Mylan
8.5. HIKMA
8.6. IPCA
8.7. SHANGHAI PHARMA
8.8. Shenhua Pharm
8.9. Sanofi
8.10. H-QYN
8.11. TAJ Pharma
8.12. MAAN Medex
8.13. Cinkate
8.14. Concordia Healthcare
8.15. Shanghai Zhongxisanwei
8.16. Wuhan Wuyao Pharmaceutical
8.17. Others
9. Finding and Conclusion
10. List of Tables
11. List of Figures
Research Methodology:
Hydroxychloroquine Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|